Drugs / Amnion collagen
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT06054646 Comparator | May 2019 → Sep 2021 | hyperpigmentation of the skin | Egyptian Atomic Energy Authority | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Amnion collagen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06054646 ↗ |
| Modality | Protein / enzyme biologic | “A collagen extract sourced from the human amniotic membrane” NCT06054646 ↗ |
| Route | Other | “treated by micro-injection of Amnion Collagen” NCT06054646 ↗ |